Suicide Prevention Month: Understanding and Responding to Suicide Risk in Older Adults

Fr. Cesar, EdD, DMin, LPC, NCC, BCC-MH

Every September, Suicide Prevention Month calls communities, clinicians, and families to action. Among the most urgent realities is the elevated suicide risk in older adults, particularly those ages 65 and above. In 2024, the CDC reported 48,824 suicide deaths nationwide; people ages 80+ had the highest age-specific rates, underscoring the vulnerability of the oldest Americans. In 2022–2024, the rate among adults 65+ averaged 17.6 per 100,000, with some states far higher—clear evidence that late life suicide remains a pressing public health concern.

Suicide lethality rises with age. Multiple CDC analyses show that rates climb across older male age groups—reaching ~40–56 per 100,000 among men ages 75–85+ in 2021—while remaining lower (though still significant) for older women. National surveillance further indicates that, in 2023, 10,437 suicide deaths occurred among adults 65+ (about 21% of all U.S. suicides that year), reflecting both demographic aging and higher case fatality in later life. By 2024, overall suicides dipped slightly from 2022’s peak, yet firearm suicides rose and older adults continued to post the highest age specific rates—an important signal for prevention strategies in this population.

The picture for attempted suicide differs: younger groups attempt more often, but older adults’ attempts are far more likely to be fatal due to method lethality (e.g., firearms) and reduced physiological resilience. Clinical literature and national resources reiterate this “high lethality, lower attempt frequency” profile in late life. While comprehensive, current national attempts data disaggregated specifically for 65+ are limited, ED surveillance confirms nonfatal self harm does occur among older adults and warrants aggressive screening and follow-up.

Risk in late life is multifactorial and often cumulative:

• Illness and hospitalization. Serious medical conditions, functional decline, and recent hospitalizations are strong correlates of suicide risk; older adults are more likely to use immediately lethal means, which raises case fatality.

• Financial stressors. Fixed incomes, medical costs, and economic insecurity contribute to demoralization and despair, which can heighten suicidal ideation.

• Worries, anxiety, and lack of socialization. Social isolation, bereavement, and loneliness are repeatedly cited drivers of late life suicide risk.

• Sadness/depression. Depression remains underrecognized and undertreated in older adults; comorbid anxiety and insomnia compound risk.

• Substance use. Opioid and sedative exposure can increase risk; psychoactive medications (e.g., hypnotics) in those 75+ are associated with higher suicide risk, particularly when combined with anxiolytics.

  
  

By definition, individuals enrolled in Medicare hospice meet criteria for a terminal illness (prognosis ≤ six months). Nationally, hospice use is widespread: ~1.8 million people received hospice care in 2022, and roughly half of Medicare decedents die while using hospice, reflecting its central role at end of life. In recent years, 51–52% of Medicare decedents have utilized hospice before death—an indicator of the scale at which terminally ill seniors receive specialized support.

Suicidal ideation and behavior do occur in palliative and hospice settings. Studies and clinical case reports emphasize early, routine screening; many patients disclose suicidal thoughts within the first month of contact—sometimes even at the first assessment—when trust and rapport are taking shape. Importantly, an emerging cohort analysis found no excess suicide mortality among oncology patients receiving palliative care compared with matched controls, suggesting that multidisciplinary palliative engagement can be protective when suicidality is proactively addressed.

At the same time, access to controlled substances in home hospice creates specific safety considerations. National surveys document concerns about medication diversion within hospice and highlight the need for vigilant protocols, clinician education, and family guidance. Hospice clinicians across the U.S. report frequent encounters with opioid misuse or substance use disorders among patients and caregivers, underscoring the importance of standardized screening, safe storage, and risk mitigation plans to reduce accidental or intentional overdose. Professional societies and palliative experts recommend structured risk assessments and compassionate, consistent engagement—without sensationalizing risk—to keep patients safe.

For families in the Chicago area, HOPE Hospice provides an interdisciplinary team—physicians, nurses, social workers, and chaplains—trained in both symptom management and mental health risk assessment across serious illness. Local program information shows HOPE’s focus on whole person care, caregiver support, and spiritual services, with clinicians accustomed to navigating complex psychosocial needs at home. In practice, that means:

• Routine screening for depression, anxiety, and suicidality, beginning at intake and repeated during transitions (e.g., posthospitalization).

• Medication safety plans (secure storage, inventory reconciliation, and education), reducing diversion and overdose risk while maintaining comfort.

• Integrated spiritual and psychosocial care, which research associates with reduced demoralization and improved coping for patients and families.

  
  

Families consistently value hospice programs that pair clinical excellence with empathy, reliability, and clear communication—features reflected in local descriptions and reviews of HOPE’s services. As you consider future hospice needs for a loved one, HOPE Hospice offers a compassionate, safety forward approach grounded in best practices for latelife mental health and endoflife care in Chicagoland.